Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Long-Term Deferred Tax (2020 - 2021)

Journey Medical's Long-Term Deferred Tax history spans 2 years, with the latest figure at $8.4 million for Q3 2021.

  • For the quarter ending Q3 2021, Long-Term Deferred Tax changed N/A year-over-year to $8.4 million, compared with a TTM value of $8.4 million through Sep 2021, changed N/A, and an annual FY2020 reading of $1.5 million, changed N/A over the prior year.
  • Long-Term Deferred Tax for Q3 2021 was $8.4 million at Journey Medical, up from $1.5 million in the prior quarter.
  • The five-year high for Long-Term Deferred Tax was $8.4 million in Q3 2021, with the low at $1.5 million in Q4 2020.